Month: January 2025

Chartwell Partners is pleased to have worked with gamma delta T cell therapy company, Adicet Bio, to recruit Julie Maltzman, MD, as Chief Medical Officer. She joins Adicet from IconOVir Bio where she served as Chief Medical Officer leading, designing, and executing on a clinical development program focused on refractory solid tumors. Prior to that,…